~~<i id='E484237865'><strike id='E484237865'><tt id='E484237865'><pre id='E484237865'></pre></tt></strike></i>~~

Home» comprehensive» fashion

fashion

author：hotspot 2025-10-02 01:40:53 Page View：547

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Burning questions about Delta and the next phase of the Covid pandemic
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

leisure time

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

My chronic pain journey would have been easier knowing 5 things % STAT

AdobeI’vebeenlivingwithchronicpainformorethanadecade.Itbeganin2009withnervedamageafteremergencygroin

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

0:21FileimageofYellowstoneNationalPark.STOCKPHOTO/GettyImagesAwomanwasfounddeadafterwhatauthoritiess

WSS

fashion

fashion

explore

leisure time

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say